About GMAGX
Invesco Advantage International Fund Class R5 is a mutual fund designed to pursue capital appreciation through diversified exposure to global markets. The fund primarily invests in a wide array of international equity securities, spanning both developed and emerging markets. It employs a dynamic allocation strategy that includes both traditional and non-traditional growth assets and strategies, allowing it to adapt to changing global economic conditions. The portfolio features holdings in major multinational companies across sectors such as technology, healthcare, financials, and telecommunications, with top positions including Taiwan Semiconductor Manufacturing, Roche, Novartis, Deutsche Telekom, UBS, and Alibaba. The fund is managed by an experienced team specializing in global asset allocation and risk management, aiming to deliver competitive performance relative to global benchmarks such as the MSCI ACWI ex USA Index. Through annual dividend and capital gain distributions, the fund supports investors seeking international diversification and long-term growth potential within their portfolios.
Fund Family Invesco
Category Foreign Large Blend
Performance Rating Average
Risk Rating Low
Stock Exchange NASDAQ
Ticker Symbol GMAGX
Index MSCI AC World ex USA NR USD
GMAGX had a total return of 33.21% in the past year, including dividends. Since the fund's
inception, the average annual return has been 14.45%.
